Zelluna ASA: Invitation to First Quarter 2025 results webcast presentation

Oslo, Norway, 30 April 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, invites to a webcast presentation of its first quarter 2025 results, on Thursday, May 8, 2025.

The presentation can be followed as a live webcast accessed through a link on www.zelluna.com at 09:00 CET on Thursday, May 8, 2025. The webcast presentation will be available on the Zelluna website, and it will be possible to post questions during the presentation through the webcast.

The report and presentation will be available on the company website from 07:00 CET the same day.

For further information, please see www.zelluna.com or contact:

For further information, please contact:

Namir Hassan, CEO, Zelluna ASA
Email: [email protected]
Phone: +44 7720 687608

Hans Vassgård Eid, CFO, Zelluna ASA
Email: [email protected]
Phone: +47 482 48632

You May Also Be Interested In

• Toll Brothers Announces New Luxury Home Community Coming Soon to Horsham, Pennsylvania
• 'Pizza for Good' Brings the Nation's Pizza Community Together to Fight Childhood Cancer
• Curebound Adds Two Accomplished Leaders to Board to Advance Bold Cancer Research